Application number | Title of the application | Filing Date | Status |
---|
07/747506 | ANTIGENS, PARTICULARLY ENVELOPE ANTIGENS OF THE VIRUS OF LYMPHADENOPATHIES AND OF THE ACQUIRED IMMUNO-DEFICIENCY SYNDROME USE OF THIS ANTIGEN IN THE PREPARATION OF IMMUNOGENIC COMPOSITIONS OR FOR THE DIAGNOSIS OF THE PRESENCE OF ANTIBODIES AGAINST THIS VIRUS | Aug 19, 1991 | Abandoned |
Array
(
[id] => 2889295
[patent_doc_number] => 05210035
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1993-05-11
[patent_title] => 'Non-reventing live vaccines'
[patent_app_type] => 1
[patent_app_number] => 7/745876
[patent_app_country] => US
[patent_app_date] => 1991-08-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16041
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/210/05210035.pdf
[firstpage_image] =>[orig_patent_app_number] => 745876
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/745876 | Non-reventing live vaccines | Aug 15, 1991 | Issued |
Array
(
[id] => 3443992
[patent_doc_number] => 05397696
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1995-03-14
[patent_title] => 'Papua New Guinea human T-lymphotropic virus'
[patent_app_type] => 1
[patent_app_number] => 7/743518
[patent_app_country] => US
[patent_app_date] => 1991-08-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 33
[patent_figures_cnt] => 35
[patent_no_of_words] => 10804
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/397/05397696.pdf
[firstpage_image] =>[orig_patent_app_number] => 743518
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/743518 | Papua New Guinea human T-lymphotropic virus | Aug 11, 1991 | Issued |
Array
(
[id] => 2973961
[patent_doc_number] => 05256534
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1993-10-26
[patent_title] => 'CD4.sup.+, latently HIV-1-infected hematopoietic progenitor cells'
[patent_app_type] => 1
[patent_app_number] => 7/742750
[patent_app_country] => US
[patent_app_date] => 1991-08-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 24
[patent_no_of_words] => 6878
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/256/05256534.pdf
[firstpage_image] =>[orig_patent_app_number] => 742750
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/742750 | CD4.sup.+, latently HIV-1-infected hematopoietic progenitor cells | Aug 8, 1991 | Issued |
Array
(
[id] => 2952433
[patent_doc_number] => 05230998
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1993-07-27
[patent_title] => 'Method for the prescreening of drugs targeted to the V3 hypervariable loop of the HIV-1 envelope glycoprotein gp 120'
[patent_app_type] => 1
[patent_app_number] => 7/735640
[patent_app_country] => US
[patent_app_date] => 1991-07-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 19
[patent_no_of_words] => 13927
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 121
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/230/05230998.pdf
[firstpage_image] =>[orig_patent_app_number] => 735640
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/735640 | Method for the prescreening of drugs targeted to the V3 hypervariable loop of the HIV-1 envelope glycoprotein gp 120 | Jul 24, 1991 | Issued |
07/732867 | SALIVARY CYTOKINES IN IMMUNOLOGICAL MONITORING | Jul 18, 1991 | Abandoned |
Array
(
[id] => 2917481
[patent_doc_number] => 05234809
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1993-08-10
[patent_title] => 'Process for isolating nucleic acid'
[patent_app_type] => 1
[patent_app_number] => 7/728007
[patent_app_country] => US
[patent_app_date] => 1991-07-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11220
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/234/05234809.pdf
[firstpage_image] =>[orig_patent_app_number] => 728007
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/728007 | Process for isolating nucleic acid | Jun 30, 1991 | Issued |
Array
(
[id] => 2882829
[patent_doc_number] => 05268265
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1993-12-07
[patent_title] => 'Immunological complex comprising an antigen of Simian Immunodeficiency Virus (SIV) and an antibody against human immunodeficiency virus type 2 (HIV 2), and method and kit for detecting antibodies to HIV-2 reactive with antigens of SIV'
[patent_app_type] => 1
[patent_app_number] => 7/703048
[patent_app_country] => US
[patent_app_date] => 1991-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 4976
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 103
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/268/05268265.pdf
[firstpage_image] =>[orig_patent_app_number] => 703048
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/703048 | Immunological complex comprising an antigen of Simian Immunodeficiency Virus (SIV) and an antibody against human immunodeficiency virus type 2 (HIV 2), and method and kit for detecting antibodies to HIV-2 reactive with antigens of SIV | May 16, 1991 | Issued |
07/701148 | METHOD OF DETECTING ANTIGENIC NUCLEIC ACID-CONTAINING MACROMOLECULAR ENTITIES | May 16, 1991 | Abandoned |
07/701626 | IMMUNOASSAYS USING ANTIGENS PRODUCED IN HETEROLOGOUS ORGANISMS | May 13, 1991 | Abandoned |
Array
(
[id] => 2780503
[patent_doc_number] => 05141742
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1992-08-25
[patent_title] => 'Vaccines against melanoma'
[patent_app_type] => 1
[patent_app_number] => 7/702142
[patent_app_country] => US
[patent_app_date] => 1991-05-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 10
[patent_no_of_words] => 13997
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/141/05141742.pdf
[firstpage_image] =>[orig_patent_app_number] => 702142
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/702142 | Vaccines against melanoma | May 12, 1991 | Issued |
Array
(
[id] => 2941142
[patent_doc_number] => 05254460
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1993-10-19
[patent_title] => 'Solvent mediated relaxation assay system'
[patent_app_type] => 1
[patent_app_number] => 7/695378
[patent_app_country] => US
[patent_app_date] => 1991-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 4692
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 101
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/254/05254460.pdf
[firstpage_image] =>[orig_patent_app_number] => 695378
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/695378 | Solvent mediated relaxation assay system | May 2, 1991 | Issued |
Array
(
[id] => 2833732
[patent_doc_number] => 05120640
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1992-06-09
[patent_title] => 'Placental isoferritins for the prognosis and diagnosis of immunosuppression'
[patent_app_type] => 1
[patent_app_number] => 7/689656
[patent_app_country] => US
[patent_app_date] => 1991-04-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 10
[patent_no_of_words] => 13219
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 93
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/120/05120640.pdf
[firstpage_image] =>[orig_patent_app_number] => 689656
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/689656 | Placental isoferritins for the prognosis and diagnosis of immunosuppression | Apr 22, 1991 | Issued |
Array
(
[id] => 3092678
[patent_doc_number] => 05298391
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1994-03-29
[patent_title] => 'Use of the SP-2 monoclonal antibody for the clinical diagnostics and for the monitoring of the HIV infection progress'
[patent_app_type] => 1
[patent_app_number] => 7/688312
[patent_app_country] => US
[patent_app_date] => 1991-04-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1517
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 140
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/298/05298391.pdf
[firstpage_image] =>[orig_patent_app_number] => 688312
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/688312 | Use of the SP-2 monoclonal antibody for the clinical diagnostics and for the monitoring of the HIV infection progress | Apr 21, 1991 | Issued |
07/680882 | PROCESS FOR THE IDENTIFICATION OR DETERMINATION OF PROTEINS, AND ITS APPLICATIONS | Apr 4, 1991 | Abandoned |
07/658460 | T-LYMPHOTROPHIC VIRUS | Feb 21, 1991 | Abandoned |
07/647209 | PURIFIED VIRUS OF LYMPHADENOPATHIES AND OF THE ACQUIRED IMMUNODEPRESSIVE SYNDROME, AND ENVELOPE ANTIGENS OF THIS VIRUS, PROCESS FOR PRODUCING THIS VIRUS AND THESE VIRUS ENVELOPE ANTIGENS, USE OF THIS VIRUS OR ANTIGENS IN THE PREPARATION OF IMMUNOGENIC COMPOS | Jan 27, 1991 | Abandoned |
Array
(
[id] => 2803812
[patent_doc_number] => 05147780
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1992-09-15
[patent_title] => 'Multiwell stat test'
[patent_app_type] => 1
[patent_app_number] => 7/644941
[patent_app_country] => US
[patent_app_date] => 1991-01-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 4
[patent_no_of_words] => 6244
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 263
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/147/05147780.pdf
[firstpage_image] =>[orig_patent_app_number] => 644941
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/644941 | Multiwell stat test | Jan 22, 1991 | Issued |
Array
(
[id] => 2893881
[patent_doc_number] => 05183735
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1993-02-02
[patent_title] => 'Method and diagnostic test kit for detection of anti-dsDNA antibodies'
[patent_app_type] => 1
[patent_app_number] => 7/633361
[patent_app_country] => US
[patent_app_date] => 1990-12-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 11789
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 164
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/183/05183735.pdf
[firstpage_image] =>[orig_patent_app_number] => 633361
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/633361 | Method and diagnostic test kit for detection of anti-dsDNA antibodies | Dec 26, 1990 | Issued |
07/632405 | ANTIGENS RELATED TO ENVELOPE GLYCOPROTEIN OF THE VIRUS OF AIDS, PARTICULARLY PRECURSORS OF GLYCOPROTEIN, METHODS OF OBTAINING THESE ANTIGENS AND MEANS EMPLOYED | Dec 19, 1990 | Abandoned |